EMEA-000499-PIP02-10-M01

Table of contents

Key facts

Active substance
Veliparib
Therapeutic area
Oncology
Decision number
P/0465/2020
PIP number
EMEA-000499-PIP02-10-M01
Pharmaceutical form(s)
  • Capsule
  • Oral liquid
Condition(s) / indication(s)
Treatment of high-grade glioma
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd

E-mail: paediatricteam@abbvie.com
Tel. +44 (0) 1628 925033

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating